Reach Us +1-218-451-2974


Keith A Josephs | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Keith A Josephs

Department of Neurology, Mayo Clinic, Rochester, MN, USA


Dr Keith A. Josephs is currently the principal investigator of multiple National Institutes of Health grants and foundation grants and co-investigator of multiple foundation grants. The research of Keith A. Josephs, M.D., focuses on the relationship between clinical diagnoses, neuroimaging and the neuropathological underpinnings accounting for neurodegenerative diseases. Neurodegenerative diseases of particular interest include progressive supranuclear palsy, corticobasal degeneration, apraxia of speech, semantic dementia, primary progressive aphasia and posterior cortical atrophy.



Symptom Prevalence of Neurodegenerative Diseases among Minorities

Background: The annual number of neurodegenerative diseases among minorities is projected to increase by 524% between 1990 and 2040 in the US and there have been no studies looking at the incidence and prevalence of signs/symptoms among different racial and ethnic minority patients with Alzheimer's dementia (AD), Parkinson's disease (PD) and Motor ... Read More»

Tarun D Singh and Keith A Josephs

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:397

DOI: 10.4172/2161-0460.1000397

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article